From Taboo to Treatment: Inside the Psychedelic Renaissance

What How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence reveals about the psychedelic renaissance

For most of the late 20th century, psychedelics were dismissed as dangerous, illegal, and scientifically irrelevant.

Then something changed.

In How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence, journalist Michael Pollan documents the quiet return of psychedelic research—and the surprising results that followed.

This isn’t a manifesto.

It’s an investigation.

And what it uncovers is a field moving from cultural taboo to serious clinical inquiry.

The Comeback Story

Pollan begins with history.

In the 1950s and early 1960s, psychedelics like:

• LSD

• Psilocybin

• Mescaline

were widely studied by scientists and psychiatrists.

Then came backlash—political, cultural, and legal. Research shut down. Funding disappeared. The field went dormant for decades.

What Pollan captures is the revival:

A new generation of researchers cautiously reopening the question:

Can these substances be used safely—and therapeutically?

What the Science Is Finding

The most compelling part of the book is its look at modern clinical research.

Under carefully controlled conditions, psychedelics are being studied for:

• Depression

• Addiction (including smoking and alcohol use)

• End-of-life anxiety in terminal illness

The pattern that emerges is striking:

• Experiences are often intense and emotionally charged

• Many participants report a sense of meaning or insight

• Some show lasting improvements in symptoms after only a few sessions

This challenges the conventional model of psychiatric treatment, which often relies on daily medication.

Instead, psychedelic therapy looks more like:

A small number of profound experiences, combined with psychological support.

The Role of the “Mystical Experience”

One of Pollan’s key observations is that outcomes often correlate with the intensity of the experience.

Participants frequently describe:

• Ego dissolution

• A sense of unity

• Encounters with something “greater”

Even in scientific settings, researchers sometimes measure something called a “mystical-type experience.”

This raises a difficult question:

Are these experiences therapeutically effective because they feel meaningful?

Pollan doesn’t fully resolve this—but he makes it clear that meaning is not a side effect.

It’s central.

Inside the Mind: What’s Actually Happening?

Pollan explores emerging neuroscience, including the idea that psychedelics disrupt rigid patterns of brain activity.

One frequently discussed concept is the default mode network (DMN)—a set of brain regions associated with self-referential thinking and the “ego.”

Under psychedelics, activity in this network appears to decrease.

The result?

• Reduced self-focus

• Increased connectivity across the brain

• A temporary loosening of entrenched mental patterns

This may help explain why psychedelics can:

• Interrupt depressive rumination

• Break addictive habits

• Create a sense of psychological “reset”

Set, Setting, and Integration

One thing Pollan emphasizes repeatedly:

Psychedelics are not magic pills.

Their effects depend heavily on:

• Set: mindset, expectations, psychological state

• Setting: physical and social environment

• Integration: how the experience is processed afterward

Modern protocols treat these as essential components—not optional extras.

This is a major shift from earlier eras of research and recreational use.

The Risks—and the Limits

Pollan is not naïve about the risks.

Psychedelics can produce:

• Anxiety and panic

• Confusion or disorientation

• Difficult psychological experiences

They are not suitable for everyone, particularly individuals with certain psychiatric conditions.

There are also open questions:

• How durable are the benefits?

• Who responds best—and why?

• How can these treatments be scaled safely?

The science is promising, but still developing.

A Personal Investigation

What sets this book apart is that Pollan doesn’t stay at a distance.

He participates.

He undergoes guided psychedelic experiences and reflects on them with a mix of curiosity and skepticism.

This adds a second layer to the book:

Not just what the science says—but what the experience feels like.

And how difficult it is to interpret.

Final Take

How to Change Your Mind doesn’t argue that psychedelics are a cure-all.

It makes a more measured claim:

Under the right conditions, these substances can catalyze meaningful psychological change.

That change may come from:

• Disrupting rigid brain patterns

• Altering the sense of self

• Creating experiences that feel deeply significant

Whether those experiences reveal truth—or simply reshape perception—is still an open question.

But one thing is clear:

The conversation around psychedelics has shifted.

From fringe to frontier.